.INVESTIGATION EMPHASIZE.16 October 2024.
In the NIAGARA litigation, the add-on of perioperative durvalumab to standard procedure for muscle-invasive bladder cancer boosted event-free and also on the whole survival, denoting a brand-new procedure choice for this ailment.